Drug Delivery News and Research

RSS

Drug delivery is a term that refers to the delivery of a pharmaceutical compound into the body. Most common methods of delivery include the preferred non-invasive oral (through the mouth), nasal, pneumonial (inhalation), and rectal routes. Much research is now focussing on nanotechnology as a drug delivery method.

Breed and placement affect skin drug delivery

Skin creams and patches might be the easiest way to give your pets medicine but their success also depends on the breed and where it’s applied.

2 Aug 2005

Mini-beacon design a major development for smart drug delivery

A nanoscopic beacon used by Melbourne researchers will help to enhance the design of smart gene and drug delivery systems.

1 Aug 2005

Amazing 'smart bomb' drug zaps cancer cells in mice without damaging healthy cells

Scientists say they have developed an anti-cancer 'bomb' which has a similar behavior to a Trojan horse.

28 Jul 2005

Cancer biology, pharmacology and engineering combine to create cancer smart bomb

Imagine a cancer drug that can burrow into a tumor, seal the exits and detonate a lethal dose of anti-cancer toxins, all while leaving healthy cells unscathed.

27 Jul 2005

GenoMed submits 50th provisional patent application

GenoMed announced today that the Company has submitted its 50th provisional patent application, a major milestone in any development stage company. GenoMed has so far been awarded two patents, one for treating acute kidney failure without dialysis, and another for hastening lung maturation in prematurely born infants.

26 Jul 2005

Orthodontics takes first step toward biological control of tooth movement

In the first study of its kind, University of Florida researchers are testing the power of a natural human hormone to biochemically move teeth faster and less painfully during orthodontic treatment.

6 Jul 2005

RxKinetix receives grant to develop thermostable vaccines with improved stability at non-refrigerated temperatures

RxKinetix Inc., a specialty pharmaceutical company has received a grant offer from the prestigious Grand Challenges in Global Health initiative. The grant will be used to develop thermostable vaccines with improved stability at non-refrigerated temperatures for use in the world's poorest countries.

30 Jun 2005

If you know how viruses get into cells, you know how to better design drugs to keep them out

When it comes to gaining entry into cells, size matters. A team from Brown University and the Max Planck Institute for Metals Research has created a model that explains how viruses and other bioparticles slip inside cells without a special protein coating called clathrin.

27 Jun 2005

Light used to regulate protein synthesis

Proteins are the puzzle-pieces of life, involved in how organisms grow and flourish, but studying their complex biological processes in living systems has been extremely difficult.

27 Jun 2005

Nanotechnology used to smuggle a powerful chemotherapeutic drug inside tumor cells

University of Michigan scientists have created the nanotechnology equivalent of a Trojan horse to smuggle a powerful chemotherapeutic drug inside tumor cells - increasing the drug's cancer-killing activity and reducing its toxic side effects.

15 Jun 2005

New Calcitonin drug delivery research holds promise for osteoporosis sufferers

Calcitonin, a hormone that lowers calcium levels in the blood and prevents bone loss, has only been available in an injectable and nasally-administered format to date.

1 Jun 2005

Ranbaxy makes further three filings of its Anti-Retroviral (ARVs) formulations

Ranbaxy Laboratories Limited has announced that the Company has made further three filings of its Anti-Retroviral (ARVs) formulations, to the World Health Organization (WHO) for its approval under the latter's pre-qualification project for HIV/AIDS drugs.

30 May 2005

Discovery of a fundamental new route into cells may lead to new methods of drug delivery

Researchers from The University of Queensland’s Institute for Molecular Bioscience (IMB), and the Centre for Microscopy and Microanalysis used electron microscopy to uncover new structures, 100,000th of a mm in size, which are involved in the very first step of particle and nutrient uptake into cells.

10 May 2005

Major Chinese breakthrough for pSivida - patent granted

This first patent grant in China is important as China has the highest incidence of primary liver cancer in the world with 345,844 cases in 2002 and is a logical target market for BrachySil. The potential lower cost of the Chinese registration pathway and the vast need of BrachySil like products make China an important commercial target.

9 May 2005

Chemical library aids in developing drug system for nerve damage

A researcher studying drug design for nerve damage therapies has gotten her answer to questions by following some old advice: she used the library.

12 Apr 2005

Significant progress in pSivida BioSilicon drug delivery evaluation

Global nanotechnology company pSivida Limited has announced that its evaluation of selected compounds from an undisclosed top five global pharmaceutical company has progressed successfully.

11 Apr 2005

Ranbaxy files additional Anti-Retroviral (ARV) agents with the World Health Organization

Ranbaxy Laboratories Limited (RLL) announced today that the Company has made two additional filings of its Anti-Retroviral (ARV) agents with the World Health Organization (WHO) for its approval, taking the total number of Ranbaxy ARV filings submitted with the WHO to five.

23 Mar 2005

Smart nanocarrier technology will cancer treatment

A ‘smart’ nanocarrier technology developed by a team of researchers at the Institute of Bioengineering and Nanotechnology (IBN) is set to vastly improve the way cancer patients are treated.

22 Mar 2005

pSivida intensifies research activities

Following extremely encouraging Phase IIa clinical trial results showing successful tumor regression and safety in man, nanotechnology pioneer pSivida Limited is intensifying development of its fully patented invention of nanostructured bioactive, biodegradable and biocompatible silicon (BioSilicon™) for multiple potential healthcare applications.

21 Mar 2005

MicroJet injector for painless injections

Parents know all too well the pain experienced by their children - and themselves - when the time comes for immunizations at the doctor's office.